These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11125999)

  • 1. Model suspensions of indomethacin "solvent deposited" on cellulose polymers.
    Bogdanova S
    Pharmazie; 2000 Nov; 55(11):829-32. PubMed ID: 11125999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluronic F-127 gels as a vehicle for topical formulations of indomethacin and rheological behaviour of these formulations.
    Shawesh A; Kallioinen S; Hellén L; Antikainen O; Yliruusi J
    Pharmazie; 2002 Mar; 57(3):186-90. PubMed ID: 11933848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates.
    Pietkiewicz J; Sznitowska M; Placzek M
    Int J Pharm; 2006 Mar; 310(1-2):64-71. PubMed ID: 16413712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization of indomethacin using hydrotropes for aqueous injection.
    Jain AK
    Eur J Pharm Biopharm; 2008 Mar; 68(3):701-14. PubMed ID: 17716879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation.
    Liu H; Finn N; Yates MZ
    Langmuir; 2005 Jan; 21(1):379-85. PubMed ID: 15620328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of hydroxy propyl guar derivative for its gelling property and it's use in the formulation of tenoxicam gels.
    Swamy NG; Dharmarajan TS; Paranjothi KL
    Pak J Pharm Sci; 2007 Jan; 20(1):61-6. PubMed ID: 17337431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and drug release investigation of amorphous drug-hydroxypropyl methylcellulose composites made via supercritical carbon dioxide assisted impregnation.
    Gong K; Rehman IU; Darr JA
    J Pharm Biomed Anal; 2008 Dec; 48(4):1112-9. PubMed ID: 18922658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.
    Azarmi S; Ghaffari F; Löbenberg R; Nokhodchi A
    Farmaco; 2005; 60(11-12):925-30. PubMed ID: 16223498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase characterization of indomethacin in adsorbates onto hydroxyethylcellulose.
    Bogdanova S; Bontcheva E; Avramova N
    Drug Dev Ind Pharm; 2007 Aug; 33(8):900-6. PubMed ID: 17729108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acceptor phosphate buffer pH value on indomethacin release.
    Vercimáková M; Vitková Z; Simunková V
    Pharmazie; 2007 Feb; 62(2):156. PubMed ID: 17341039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiation.
    Fernández-Carballido A; Puebla P; Herrero-Vanrell R; Pastoriza P
    Int J Pharm; 2006 Apr; 313(1-2):129-35. PubMed ID: 16495023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved dissolution rate of indomethacin by adsorbents.
    Alsaidan SM; Alsughayer AA; Eshra AG
    Drug Dev Ind Pharm; 1998 Apr; 24(4):389-94. PubMed ID: 9876600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of indomethacin Carbopol ETD 2001 gels and the influence of storage time and temperature on their stability.
    Shawesh AM; Kaukonen A; Kallioinen S; Antikainen O; Yliruusi J
    Pharmazie; 2003 Feb; 58(2):130-5. PubMed ID: 12641331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
    Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
    Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
    J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.